SUMMARY This study was initiated to determine if raised (carcinoid) plasma concentrations of substance P induced jejunal secretion of water and electrolytes. Five dogs had isolated and cannulated 25 cm jejunal segments perfused at 2 ml/min with a neutral, isotonic perfusate. Saline, 1 0 ml, was infused intravenously during basal and recovery periods, while substance P was administered intravenously at 75 ng/kg/min (55 pmol/kg/min) during the four 15 minute experimental periods. Infusion increased plasma SP concentrations from basal (5.8±1.3 pg/ml) to a mean plateau level of 121-2±25.2 pg/ml (mean±SEM). During SP infusion, intestinal secretion of water, Na+, and Cl-were documented (H20 basal +102±60 to SP -275±60; R,Imin; Na+ basal +19-8±7-2 to SP -23-2±7 5 ,uEq/min; Cl-basal 21-7±7-5 to SP -16-5±5-6 [iEq/min).Under basal conditions, there was minimal secretion of potassium (-0264±0282 ,Eq/min); during SP infusion, K+ flux was altered to significant secretion (-1 784±0271 ,tEq/min). Serum concentrations of Na and Cl were unchanged during SP infusion, but serum potassium concentrations fell from 4.64±0-12 to 3 85±040 mEq/l. The data demonstrate that substance P at levels noted in the carcinoid syndrome induces significant jejunal secretion of water and electrolytes in the dog.In 1931 von Euler and Gaddum described a hypotensive and spasmogenic extract from horse brain and intestine and named it substance P.1 This extract was later shown to be an 11 amino acid oligopeptide extensively distributed in both the nervous and gastrointestinal systems. Central nervous system substance P is predominantly localised within the grey matter, the dorsal half of the spinal cord, and the primary sensory neurones of the spinal ganglia.2 3 In the gastrointestinal tract SP is diffusely distributed, with the highest concentrations in the small intestine.4 5 Intramural intestinal substance P has been localised in the mucosal enterochromaffin cells6 and most components of the submucosal nervous plexus.2Various systemic actions have been attributed to substance P including alterations in the distribution of blood flow,7 8 glucose homeostasis,9 and water balance.10 Gastrointestinal manifestations of the peptide include profound increases in motility,2 1' alterations in exocrine biliary and pancreatic secre-